This proposal seeks a competing continuation of R01 HL52555-09. Mitogen-activated protein kinases (MAPKs) serve diverse functions in biological signaling relays, including cascades for cardiac development, hypertrophy, and the transition to heart failure. The Applicant's investigations are directed at decoding the biological function of proximal MAPKs in the myocardium mMAP kinase kinase kinases (MAP3Ks) and MAP kinase kinase kinase kinases (MAP4Ks) that fall close to signal generation in the hierarchy of signaling events. Transforming growth factor beta-activated kinase-1 (TAK1, MAP3K7) and its activation are especially well-suited for such studies. Work performed during our prior period of support has established that TAK1 modulates the AMP-activated protein kinase (AMPK) energy sensor pathway for glycogen storage cardiomyopathy and Wolff-Parkinson-White syndrome. Also, we recently identified a novel feed-forward circuit that amplifies cardiac apoptotic signals, reciprocally coupling levels of TRF2, a telomere-capping protein, to TAK1 via MAP4K4 (hematopoietic progenitor kinase/germinal cell kinase-like kinase, HGK). Alternative splicing of HGK exon 16 results in two transcdpts that differ by the inclusion or exclusion of an SH3 domain and are co-expressed at equal levels in myocardium. Interesting, in acute cell culture studies, we found only the short form of HGK leads to myocyte apoptosis. Decimation of Baylor's vivarium by Tropical Storm Allison in June 2001 set back our expected progress towards the conditional deletion of TAK1 and HGK by roughly two years. However, we now have germline transmission or, minimally, chimeric mice for all three """"""""floxed"""""""" alleles required in this project. We propose: (1) To determine the critical function(s) of endogenous TAK1, using conditional dominant-negative and loss-of-function mutations. (2) To study the essential function(s) of endogenous HGK, a TAKl-activating kinase, using a conditional loss-of-function mutation and conditional deletion of the alternatively spliced SH3 domain.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
7R01HL052555-14
Application #
7662965
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Schramm, Charlene A
Project Start
1995-08-01
Project End
2009-11-30
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
14
Fiscal Year
2007
Total Cost
$43,200
Indirect Cost
Name
U of L Imperial Col of Sci/Technlgy/Med
Department
Type
DUNS #
227092590
City
London
State
Country
United Kingdom
Zip Code
SW7 2-AZ
Chuang, Huai-Chia; Sheu, Wayne H-H; Lin, Yi-Ting et al. (2014) HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun 5:4602
Greenblatt, Matthew B; Shim, Jae-Hyuck; Zou, Weiguo et al. (2010) The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest 120:2457-73
Shim, Jae-Hyuck; Greenblatt, Matthew B; Xie, Min et al. (2009) TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J 28:2028-41
Abdellatif, M; Packer, S E; Michael, L H et al. (1998) A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy. Mol Cell Biol 18:6729-36
Charng, M J; Zhang, D; Kinnunen, P et al. (1998) A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor. J Biol Chem 273:9365-8
Agah, R; Kirshenbaum, L A; Abdellatif, M et al. (1997) Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 100:2722-8
MacLellan, W R; Schneider, M D (1997) Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81:137-44
Agah, R; Frenkel, P A; French, B A et al. (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-79
Charng, M J; Kinnunen, P; Hawker, J et al. (1996) FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors. J Biol Chem 271:22941-4
Kirshenbaum, L A; Abdellatif, M; Chakraborty, S et al. (1996) Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev Biol 179:402-11